XML 41 R27.htm IDEA: XBRL DOCUMENT
v3.20.2

Investments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2020
Investments [Abstract] |
Schedule of Long-term Investments | The below equity investments are included in investments on the condensed consolidated balance sheets (in thousands):
Equity Investments Without Readily Determinable Fair Values |  | September 30, 2020 |  | December 31, 2019
Respicardia Inc. (1) |  | $ | 17,706 |  |  | $ | 17,706 |
ALung Technologies, Inc. (2) |  | 3,000 |  |  | — |
Ceribell, Inc. |  | 3,000 |  |  | 3,000 |
ShiraTronics, Inc. |  | 2,045 |  |  | 2,045 |
MD Start II |  | 1,169 |  |  | 1,121 |
Rainbow Medical Ltd. |  | 1,145 |  |  | 1,099 |
Highlife S.A.S. |  | 1,109 |  |  | 1,064 |
Other |  | 770 |  |  | 770 |
|  | 29,944 |  |  | 26,805 |
Equity method investment |  | 414 |  |  | 451 |
|  | $ | 30,358 |  |  | $ | 27,256 |
(1)Respicardia Inc. (“Respicardia”) is a privately funded U.S. company developing an implantable device designed to restore a more natural breathing pattern during sleep in patients with central sleep apnea by transvenously stimulating the phrenic nerve. We have a loan outstanding to Respicardia, with a carrying amount of $0.8 million and $0.6 million as of September 30, 2020 and December 31, 2019, respectively, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet. (2)During the first quarter of 2020, we invested in ALung Technologies, Inc. (“ALung”). ALung is a privately held medical device company focused on creating advanced medical devices for treating respiratory failure. ALung’s Hemolung Respiratory Assist System is a dialysis-like alternative or supplement to mechanical ventilation which removes carbon dioxide directly from the blood in patients with acute respiratory failure. During the second quarter of 2020, we provided a convertible loan to ALung for $2.0 million, due July 10, 2021. As of September 30, 2020, the carrying amount of the loan was $2.0 million, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.

X
- Definition Tabular disclosure of investment in equity security without readily determinable fair value. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 321 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714 + Details
Name: | us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration